Adicet Bio 13D/A Filed by Investor Group: SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech. 👈 Read full analysis #AdicetBio #Investing #Biotech #ClinicalStage #InvestorGroup
Adicet Bio 13D/A Filed by Investor Group
SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech.
dlvr.it
April 11, 2026 at 1:23 AM
Adicet Bio 13D/A Filed by Investor Group: SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech. 👈 Read full analysis #AdicetBio #Investing #Biotech #ClinicalStage #InvestorGroup
Adicet Bio Form 144 Filed Apr 7: Form 144 filed Apr 7, 2026 for Adicet Bio; SEC Rule 144 requires filings above $50,000 or 5,000 shares and grants a 90-day sale window. 👈 Read full analysis #AdicetBio #Form144 #SEC #stockmarket #investing
Adicet Bio Form 144 Filed Apr 7
Form 144 filed Apr 7, 2026 for Adicet Bio; SEC Rule 144 requires filings above $50,000 or 5,000 shares and grants a 90-day sale window.
dlvr.it
April 8, 2026 at 1:51 AM
Adicet Bio Form 144 Filed Apr 7: Form 144 filed Apr 7, 2026 for Adicet Bio; SEC Rule 144 requires filings above $50,000 or 5,000 shares and grants a 90-day sale window. 👈 Read full analysis #AdicetBio #Form144 #SEC #stockmarket #investing